Summary Of Loading Off Bottom - As At Close May 22.

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
246
Summary Of Loading Off Bottom - As At Close May 22.

Bought at .4000:

Aug 29: 400

Bought at .3500:

Aug 29: 100

Bought at .3000 / .3200 / .3275

Aug 28: 42,000
Oct 24: 2,599
Oct 26: 7,635
Oct 29: 4,915
Oct 30: 900

Total: 58,049

Bought at .2500 / .2553 / .2600 / .2779 / .2788 / .2800 / .2843 / .2887 / .2888 / .2998 / .2999

Sep 24: 45,374
Sep 15: 124
Oct 2: 990
Oct 18: 26,616
Oct 19: 25,000
Oct 22: 11,500
Oct 23: 10,000
Oct 24: 10,000
Jan 2: 1,000

Total: 130,604

Bought at .2100 / .2194 / .2300 / .2325 / .2350 / .2400 / .2469:

Aug 29: 200
Sep 24: 5,194
Sep 27: 2,425
Oct 1: 10,000
Oct 12: 155
Oct 22: 520
Oct 26: 8
Oct 30: 30
Nov 5: 1
Nov 8: 3,469
Nov 9: 800
Nov 27: 5,150
Dec 4: 400
Dec 14: 1,490
Dec 18: 3,245
Dec 28: 132
Jan 7: 500
Feb 14: 503

Total: 34,212

Bought at .2000:

Aug 28: 63,000
Sep 21: 6,499
Sep 25: 10
Sep 26: 2,500
Feb 14: 100
Feb 26: 500
Feb 27: 383
Mar 4: 533

Total: 73,025

Bought at .1600 / .1650 / .1670 / .1690 / .1700 / .1800 / .1900 / .1940 / .1995:

Aug 31: 800
Sep 21: 2,683
Oct 2: 200
Oct 8: 10,000
Oct 15: 613
Oct 16: 5,187
Oct 17: 2,500
Nov 8: 9,100
Nov 9: 1,300
Nov 12: 10,130
Nov 13: 10,000
Nov 14: 8,008
Jan 10: 22,000
Mar 21: 100
Mar 22: 100

Total: 80,621

Bought at .1500 / .1501 / .1510 / .1525 /.1530 / .1550:

Aug 31: 1,990
Sep 21: 14,154
Oct 10: 413
Oct 11: 300
Oct 12: 200
Oct 15: 9,387
Nov 16: 1
Nov 19: 66
Nov 27: 150
Dec 31: 764
Jan 7: 11
Jan 8: 3,572
Jan 22: 2
Feb 1: 1,500
Mar 4: 1,180
Mar 6: 150

Total: 33,840

Bought at .1425 / .1450 / .1475:

Sep 13: 1,541
Sep 14: 580
Sep 18. 20,000

Total: 22,121

Bought at .1400:

Aug 31: 6,800
Sep 5: 100
Sep 12: 19,900

Total: 26,800

Bought at .1300 / .1350:

Aug 31: 9,900
May 21: 100
May 22: 100

Total: 10,100

Bought at .1200 / .1250 / .12555 / .1270:

Aug 30: 8,000
Aug 31: 999
Sep 17: 5,100
Sep 18: 6,200
Sep 20: 1,260
Nov 30: 75
Dec 3: 50
Dec 6: 9
Dec 10: 1
Dec 17: 1
Dec 28: 700

Total: 22,395

Bought at .10505 / .1010 / .1075 / .1100 / .1150

Sep 5: 5,000
Dec 24: 20
Jan 9: 33
Jan 22: 1
Jan 24: 4
Jan 25: 1,001
Jan 26: 7,493
Feb 8: 400
Feb 20: 5
Feb 21: 2
Mar 12: 2
Apr 2: 311
May 7: 480

Total: 14,752

Bought at .1000:

Aug 28: 245,000
Aug 31: 55,512
Sep 4: 9,905
Sep 12: 5,000
Feb 20: 5
Feb 26: 100
Feb 27: 528
Feb 28: 850
Mar 1: 65
Mar 4: 1
Mar 6: 206
Mar 8: 3,277
Mar 19: 300
Apr 2: 4,397
Apr 3: 167
Apr 4: 1,202
Apr 5: 1,500
Apr 15: 2,923
Apr 22: 1
Apr 23: 201
May 2: 2
May 7: 30
May 10: 1
May 14: 1,363
May 15: 55
May 21:18

Total: 332,609

Bought at .0900:

Sep 12: 995

Bought at .8000 / .0850:

Sep 10: 3,370
Sep 11: 3,099

Total: 3,470

Bought at .0701:

Sep 5: 26
Sep 6: 2,917
Sep 7: 4,926
Sep 10: 6,390

Total: 14,259

Notes:
Nobody had .1s (.0001s) previously.
Very few had .2 (.0002s) previously - only 5M from 2018 prior to Aug 28.





American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 169

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 133

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 563

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 555

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 404

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 207

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 164

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 315

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 83

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 61

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Interoperability: The Free Partner Edition by interop.io

Updated Category News Views 230

Unlocking New Potential in Fintech with Free Edition interop.io, known as a frontrunner in desktop interoperability, is set to revolutionize the way fintech companies operate with the introduction of a cost-free edition of their software suite, named io.Connect. This new initiative aims to provide fintechs, regardless of their size or stage, with the opportunity to adopt...

Continue Reading
Massage Envy Celebrates Scholarship Winners and Their Future

Updated Category News Views 164

Massage Envy Celebrates Scholarship Winners Eight outstanding individuals have been recognized as winners of the Massage Envy National Scholarship Sweepstakes, each receiving a $2,500 scholarship to support their journey into the massage therapy profession. This initiative demonstrates Massage Envy's commitment to fostering the next generation of talented massage...

Continue Reading
Paul Mueller Company Updates Investors on Dividend Plans

Updated Category News Views 397

Paul Mueller Company Declares Cash Dividend Paul Mueller Company (OTC: MUEL) has some exciting news for its investors. The company has recently announced that its Board of Directors has declared a cash dividend of $0.30 per share on its outstanding common stock. This dividend reflects the company’s ongoing commitment to providing value to its shareholders. Details of...

Continue Reading
Photocure Enhances Leadership with Jane Healy as GM EMEA

Updated Category News Views 360

Photocure Welcomes Jane Healy as Vice President and General Manager EMEA Photocure ASA (OSE: PHO), known as the Bladder Cancer Company, has made a significant move by appointing Jane Healy as the new Vice President and General Manager for the EMEA region. This strategic decision underscores Photocure's commitment to enhancing its leadership in the uro-oncology sector....

Continue Reading
TDS Hits Bumps but Keeps Shareholders Happy

Updated Category News Views 48

High Hopes and Hard Hits: TDS in 2026 Listen up, folks. Telephone and Data Systems, Inc. (NYSE: TDS) just popped the hood on their third quarter earnings, and it's a mixed bag with plenty to chew over. Operating revenues are slightly down from last year, but management's got some tricks up their sleeves. CEO Walter Carlson is trumpeting their expanded fiber service...

Continue Reading